Archive | Reading List RSS feed for this section

Biotech Funds and ETFS:JNGLX,FBDIX,FBIOX

See This Week’s issue of Barron’s (JY 15 p 31)  for a good  summary of the  biotech sector.  See also our article at bottom of page from Investor Uprising in 2011.We have covered many ETFs and funds over the years and have favored Fidelity Select Biotechnology Fund (FBIOX) and ETFs such as IBB and XBI. […]

Comments Off Continue Reading →

When Does the Cost of Cancer Drugs Affect the Market?

Cancer’s Bitter Medicine Alex Philippidis in today’s Genetic Engineering News provides an excellent review of the treatment costs for CML (chronic myeloid leukemia) which can exceed $100k/year. However concern about the costs of cancer treatment has not yet hit the radar screen of major biotechnology analysts. Biopharmaceutical stocks are at an all time high due […]

Comments Off Continue Reading →

Biotechnology Archives: Human Genome Sciences-Anthrax and Lupus

1999 Biotech Superstar Got Bailed Out By Anthrax antitoxin?! The famous Company that was going to revolutionize drug discovery was saved in 2003 by a government funded bioterror program for Anthrax and later a Lupus drug. Anthrax drug brings $334 million to Pentagon advisor’s biotech firm – latimes.com Human Genome Sciences was sold to Glaxo […]

Comments Off Continue Reading →

Targeted Therapy and Diagnostic Biomarker Studies and Services 3/3/13 Update GHDX

Genomic Health Up 5% on Higher Q1 Revenues An article in the New York Times today (May 2) by Gina Kolata reviewed studies that affirmed the genetic basis of cancer. Genetic analysis of hundreds of tumors for endometrial cancer and leukemias found patterns of genetic aberrations that more precisely classify tumors. Knowing which genes are […]

Comments Off Continue Reading →

Rayno Life Sciences: Investor Election Guide from Credit Suisse

Ultimate Presidential Election Guide Click above for an interesting sector and stock review from Credit Suisse including major positions of candidates. Stocks in the Rayno Life Sciences Portfolio that were mentioned on the “Obama Victory” side include: Illumina (ILMN) and ThermoFisher (TMO) On the “Romney Victory” side include many medTech stocks such as Baxter (BAX) […]

Comments Off Continue Reading →

Biotechnology Does Create Jobs and MASS Effort pays Off

The MASS Biotechnology industry has crossed $6B as a 25 year effort beginning in 1985 with the MASS Biotechnology Council. Several major biotechnology companies were created around this time such as Biogen(BIIB)  and Vertex (VRTX) as well as major venture capital firms who invested $1B in 2011 and $8B since 2002. Several major pharmaceutical firms […]

Comments Off Continue Reading →